US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 11.180
  • -0.250-2.19%
Close Feb 14 16:00 ET
  • 11.180
  • 0.0000.00%
Post 20:01 ET
391.28MMarket Cap-29.42P/E (TTM)

Oruka Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
--410.88M
--15.12M
--27.74M
-Cash and cash equivalents
--410.88M
--15.12M
--27.74M
Receivables
--0
--0
--0
Prepaid assets
----
--1.43M
----
Other current assets
--2.07M
--275K
----
Total current assets
--412.95M
--16.82M
--27.74M
Non current assets
Net PPE
--1.1M
--999K
----
-Gross PPE
--1.1M
--999K
----
Other non current assets
--43K
--2.36M
--488K
Total non current assets
--1.14M
--3.36M
--488K
Total assets
--414.09M
--20.18M
--28.23M
Liabilities
Current liabilities
Payables
--8.5M
--18.02M
--5.9M
-accounts payable
--8.5M
--2.58M
--5.9M
-Due to related parties current
----
--15.44M
----
Current accrued expenses
--777K
--795K
--1.13M
Current debt and capital lease obligation
--146K
--61K
----
-Current capital lease obligation
--146K
--61K
----
Other current liabilities
--7.68M
--430K
--56K
Current liabilities
--18.04M
--19.36M
--7.17M
Non current liabilities
Long term debt and capital lease obligation
--842K
--25.91M
--24.98M
-Long term debt
----
--24.98M
--24.98M
-Long term capital lease obligation
--842K
--925K
----
Non current accrued expenses
----
--961K
--214K
Preferred securities outside stock equity
--52.84M
--2.93M
--2.93M
Total non current liabilities
--53.68M
--29.8M
--28.13M
Total liabilities
--71.72M
--49.16M
--35.29M
Shareholders'equity
Share capital
--2.97M
--0
--1K
-common stock
--35K
--0
--1K
-Preferred stock
--2.93M
----
----
Retained earnings
---57.94M
---29.32M
---7.08M
Paid-in capital
--397.35M
--339K
--17K
Total stockholders'equity
--342.37M
---28.98M
---7.06M
Total equity
--342.37M
---28.98M
---7.06M
Currency Unit
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments --410.88M--15.12M--27.74M
-Cash and cash equivalents --410.88M--15.12M--27.74M
Receivables --0--0--0
Prepaid assets ------1.43M----
Other current assets --2.07M--275K----
Total current assets --412.95M--16.82M--27.74M
Non current assets
Net PPE --1.1M--999K----
-Gross PPE --1.1M--999K----
Other non current assets --43K--2.36M--488K
Total non current assets --1.14M--3.36M--488K
Total assets --414.09M--20.18M--28.23M
Liabilities
Current liabilities
Payables --8.5M--18.02M--5.9M
-accounts payable --8.5M--2.58M--5.9M
-Due to related parties current ------15.44M----
Current accrued expenses --777K--795K--1.13M
Current debt and capital lease obligation --146K--61K----
-Current capital lease obligation --146K--61K----
Other current liabilities --7.68M--430K--56K
Current liabilities --18.04M--19.36M--7.17M
Non current liabilities
Long term debt and capital lease obligation --842K--25.91M--24.98M
-Long term debt ------24.98M--24.98M
-Long term capital lease obligation --842K--925K----
Non current accrued expenses ------961K--214K
Preferred securities outside stock equity --52.84M--2.93M--2.93M
Total non current liabilities --53.68M--29.8M--28.13M
Total liabilities --71.72M--49.16M--35.29M
Shareholders'equity
Share capital --2.97M--0--1K
-common stock --35K--0--1K
-Preferred stock --2.93M--------
Retained earnings ---57.94M---29.32M---7.08M
Paid-in capital --397.35M--339K--17K
Total stockholders'equity --342.37M---28.98M---7.06M
Total equity --342.37M---28.98M---7.06M
Currency Unit USDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Trending Stocks

Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More